Victor M Blanco1, Juan J Maya2, Adriana Correa3, Marcela Perenguez3, Juan S Muñoz3, Gabriel Motoa3, Christian J Pallares4, Fernando Rosso5, Lorena Matta6, Yamile Celis7, Martha Garzon8, María V Villegas9. 1. Centro Internacional de Entrenamiento e Investigaciones Médicas - CIDEIM, Cali, Colombia; Fundación Clínica Valle del Lili, Cali, Colombia; Universidad ICESI, Cali, Colombia. 2. Cleveland Clinic Foundation, Cleveland, Ohio, Estados Unidos. 3. Centro Internacional de Entrenamiento e Investigaciones Médicas - CIDEIM, Cali, Colombia. 4. Centro Internacional de Entrenamiento e Investigaciones Médicas - CIDEIM, Cali, Colombia; Hospital Universitario del Valle Evaristo García «E. S. E.», Cali, Colombia. 5. Fundación Clínica Valle del Lili, Cali, Colombia; Universidad ICESI, Cali, Colombia. 6. Clínica Universitaria Rafael Uribe Uribe, Cali, Colombia. 7. Laboratorio de Salud Pública, Secretaría de Salud de Bogotá, Bogotá, Colombia. 8. Hospital El Tunal, Bogotá, Colombia. 9. Centro Internacional de Entrenamiento e Investigaciones Médicas - CIDEIM, Cali, Colombia. Electronic address: mariavirginia.villegas@gmail.com.
Abstract
INTRODUCTION: Urinary tract infections (UTI) are common in the community. However, information of resistant isolates in this context is limited in Latin America. This study aims to determine the prevalence and risk factors associated with community-onset UTI (CO-UTI) caused by extended-spectrum β-lactamase (ESBL)-Producing Escherichia coli in Colombia. MATERIALS AND METHODS: A case-control study was conducted between August and December of 2011 in three Colombian tertiary-care institutions. All patients who were admitted to the Emergency Department with a probable diagnosis of CO-UTI were invited to participate. All participating patients were asked for a urine sample. ESBL confirmatory test, antibiotic susceptibility, and molecular epidemiology were performed in these E.coli isolates (Real Time-PCR for bla genes, repetitive element palindromic PCR [rep-PCR], multilocus sequence typing [MLST] and virulence factors by PCR). Clinical and epidemiological information was recorded, and a statistical analysis was performed. RESULTS: Of the 2124 recruited patients, 629 had a positive urine culture, 431 of which grew E.coli; 54 were positive for ESBL, of which 29 were CTX-M-15. The majority of ESBL isolates were susceptible to ertapenem, phosphomycin and amikacin. Complicated UTI was strongly associated with ESBL-producing E.coli infections (OR=3.89; 95%CI: 1.10-13.89; P=.03). CTX-M-15-producing E.coli showed 10 different pulsotypes, 65% were PT1 or PT4, and corresponded to ST131. Most of these isolates had 8 out of the 9 analysed virulence factors. DISCUSSION: E.coli harbouring blaCTX-M-15 associated with ST131 is still frequent in Colombia. The presence of complicated CO-UTI increases the risk of ESBL-producing E.coli, and must be taken into account in order to provide an adequate empirical therapy.
INTRODUCTION:Urinary tract infections (UTI) are common in the community. However, information of resistant isolates in this context is limited in Latin America. This study aims to determine the prevalence and risk factors associated with community-onset UTI (CO-UTI) caused by extended-spectrum β-lactamase (ESBL)-Producing Escherichia coli in Colombia. MATERIALS AND METHODS: A case-control study was conducted between August and December of 2011 in three Colombian tertiary-care institutions. All patients who were admitted to the Emergency Department with a probable diagnosis of CO-UTI were invited to participate. All participating patients were asked for a urine sample. ESBL confirmatory test, antibiotic susceptibility, and molecular epidemiology were performed in these E.coli isolates (Real Time-PCR for bla genes, repetitive element palindromic PCR [rep-PCR], multilocus sequence typing [MLST] and virulence factors by PCR). Clinical and epidemiological information was recorded, and a statistical analysis was performed. RESULTS: Of the 2124 recruited patients, 629 had a positive urine culture, 431 of which grew E.coli; 54 were positive for ESBL, of which 29 were CTX-M-15. The majority of ESBL isolates were susceptible to ertapenem, phosphomycin and amikacin. Complicated UTI was strongly associated with ESBL-producing E.coli infections (OR=3.89; 95%CI: 1.10-13.89; P=.03). CTX-M-15-producing E.coli showed 10 different pulsotypes, 65% were PT1 or PT4, and corresponded to ST131. Most of these isolates had 8 out of the 9 analysed virulence factors. DISCUSSION: E.coli harbouring blaCTX-M-15 associated with ST131 is still frequent in Colombia. The presence of complicated CO-UTI increases the risk of ESBL-producing E.coli, and must be taken into account in order to provide an adequate empirical therapy.
Authors: Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper Journal: Clin Infect Dis Date: 2011-03-01 Impact factor: 9.079
Authors: P Cassier; S Lallechère; S Aho; K Astruc; C Neuwirth; L Piroth; P Chavanet Journal: Clin Microbiol Infect Date: 2011-04-12 Impact factor: 8.067
Authors: Liliane Miyuki Seki; Polyana Silva Pereira; Magda de Souza Conceição; Maria José Souza; Elizabeth Andrade Marques; Jupira Miron Carballido; Maria Elisabeth Serqueira de Carvalho; Ana Paula D'Alincourt Carvalho Assef; Marise Dutra Asensi Journal: Braz J Infect Dis Date: 2013-09-20 Impact factor: 3.257
Authors: Sandra Yamile Saavedra; Lorena Diaz; Magdalena Wiesner; Adriana Correa; Stefany Alejandra Arévalo; Jinnethe Reyes; Andrea Melissa Hidalgo; Elsa de la Cadena; Marcela Perenguez; Lucy Angeline Montaño; Javier Ardila; Rafael Ríos; María Victoria Ovalle; Paula Díaz; Paola Porras; Maria V Villegas; Cesar A Arias; Mauricio Beltrán; Carolina Duarte Journal: Antimicrob Agents Chemother Date: 2017-11-22 Impact factor: 5.191
Authors: Carlos Bastidas-Caldes; Daniel Romero-Alvarez; Victor Valdez-Vélez; Roberto D Morales; Andrés Montalvo-Hernández; Cicero Gomes-Dias; Manuel Calvopiña Journal: Infect Drug Resist Date: 2022-09-30 Impact factor: 4.177